Inspire Investing’s MacroGenics MGNX Stock Holding History

Inspire Investing’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81	Hold	18	–	–	﹤0.01%	1228
2026 Q1	$51	Buy	18 +4	+29%	+$9	﹤0.01%	1072
2025 Q4	$23	Buy	+14	New	+$22	﹤0.01%	1100
2020 Q2	–	Sell	-43	Closed	–	–	626
2020 Q1	$0	Buy	+43	New	+$390	﹤0.01%	769
2018 Q1	–	Sell	-72	Closed	-$1K	–	496
2017 Q4	$1K	Buy	+72	New	+$1.34K	﹤0.01%	877

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Inspire Investing's MGNX Position: Q2 2026 in Review

Inspire Investing held its MacroGenics (MGNX) position steady in Q2 2026 at 18 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #1228.

Inspire Investing first reported a position in MGNX in Q4 2017 and has held it in 5 quarters since. The position peaked at $1K in Q4 2017. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Inspire Investing held 18 shares of MacroGenics worth $81 as of Q2 2026.
Inspire Investing left its MacroGenics share count unchanged in Q2 2026.
MacroGenics made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1228 holding.
Inspire Investing first reported a position in MacroGenics in Q4 2017 and has held it in 5 quarters since.
Inspire Investing's MacroGenics position peaked at $1K in Q4 2017.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.